Clinical characteristics of human Leishmania braziliensis braziliensis infections.
D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D007897:Leishmaniasis, Mucocutaneous / Q000175:diagnosis* / Q000188:drug therapy; D008536:Meglumine; D000077485:Meglumine Antimoniate; D009092:Mucous Membrane / Q000473:pathology; D009942:Organometallic Compounds
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony